Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of Samotolisib in Healthy Subjects
NCT02818335Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of samotolisib in solid tumor (3 arms), sponsored by Eli Lilly and Company. Primary endpoints: Area under the concentration versus time curve from time zero to infinity, Area under the concentration from time zero to time t and 2 more. Started Jul 2016; status: completed.
02
Drugs
samotolisib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02818335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02818335.